Lineagen Incorporating Affymetrix's GeneChip Technology into Genetic Evaluation Service | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lineagen will incorporate Affymetrix's GeneChip technology into its genetic evaluation service for patients with developmental delay, intellectual disability, and autism spectrum disorders, under a deal announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.